What is EVGN's P/E ratio?

EVOGENE (EVGN) currently trades at a P/E ratio of 1.53.

EVOGENE reports a Return on Equity (ROE) of 462.36%.

What is EVGN's dividend yield?

EVOGENE offers a dividend yield of 0.00%.

What is EVGN's Quality Score?

Our AI rates EVGN's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy EVGN?

Our AI Timing Score for EVGN is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does EVGN belong to?

EVOGENE is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

EVGN (NASDAQ) Stock Analysis | EVOGENE

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

EVGN AI Analysis Summary

Our AI summary for EVGN: EVOGENE (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 1.53, ROE of 462.36%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

EVGN

EVOGENE

US:NASDAQ STOCK Healthcare >> Biotechnology News 72

USD 0.47

-0.02 (-3.76%) Day Change

Watchlist Portfolio Compare Chart

1.53

P/E

-0.26

D/E

462.4%

ROE

-65.6%

ROA

0.00%

Div Yield

-0.04

PEG

EVOGENE
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.47 Price -0.02 (-3.76%) Day Change	NEWS SCORE: 72

EVGN, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

57%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	72
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.47
PBV / Sector	0.74 / 5.20 GREAT
Earning Per Share	-0.94

PE / Sector	1.53 / 19.97 GREAT
PEG or PE/Growth / Sector	-0.04 / 1.22
Average 1M Daily Value	1.00 M GREAT
Average 1W Daily Value	0.04 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

58%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-638.12 / 98.71
NPM Average (%) / Sector	-709.01 / -1,721.76
NPM Change Average (%) / Sector	12.88 / 5,211.62 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-65.56 / 27.02
ROA Average (%) / Sector	-48.69 / -368.17
ROA Change Average (%) / Sector	11.05 / 5,404.12 GOOD
ROE (%) / Sector	462.36 / 3.47 GREAT
ROE Average (%) / Sector	2,330.51 / 6.51
ROE Change Average (%) / Sector	37.38 / 2,128.13 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 07:59:48
Symbol	EVGN
Name	EVOGENE
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	12.10 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	5.92 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 13 Gad Feinstein Street, Rehovot, Israel, 7638517

Phone: 972 8 931 1900

Website: https://www.evogene.com

Employees: 52

Sector: Healthcare >> Biotechnology

Description: Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel.